REQUEST A DEMO
Total
USD $0.00
Search more companies

RZSBT Pharma Zrt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Electronic Shopping and Mail-Order Houses
Full name: RZSBT Pharma Zrt. Profile Updated: August 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Hungarian Download a sample report

RZSBT Pharma Zrt. is an enterprise in Hungary, with the main office in Budapest. The company operates in the Pharmacies and Drug Stores industry. The company was established on April 06, 2022. 11 (2026) employees currently work for RZSBT Pharma Zrt.. In its most recent financial highlights, the company reported a net sales revenue increase of 25.52% in 2025. A growth of 48.23% was recorded in its total assets. The net profit margin of RZSBT Pharma Zrt. decreased by 5.07% in 2025.

Headquarters
Szekelyhid utca 23. fszt. 4.
Budapest; Budapest; Postal Code: 1204

Contact Details: Purchase the RZSBT Pharma Zrt. report to view the information.

Basic Information
Total Employees:
Purchase the RZSBT Pharma Zrt. report to view the information.
Registered Capital:
Purchase the RZSBT Pharma Zrt. report to view the information.
Financial Auditors:
Purchase the RZSBT Pharma Zrt. report to view the information.
Incorporation Date:
April 06, 2022
Key Executives
Purchase this report to view the information.
Trustee
Purchase this report to view the information.
Trustee
Purchase this report to view the information.
Trustee
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after RZSBT Pharma Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
25.52%
Total Operating Revenue
25.5%
Operating Profit
-64.52%
EBITDA
-60.05%
Net Profit/Loss for the Period
-65.11%
Total Assets
48.23%
Total Equity
-72.91%
Operating Profit Margin
-5.6%
Net Profit Margin
-5.07%
Return on Equity (ROE)
18.62%
Quick Ratio
-0.78%
Cash Ratio
-0.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?